Showing 1 - 10 of 244
Trust in the health care system requires being confident that sufficient and appropriate treatments will be provided if needed. The COVID-19 public health crisis is a significant, global, and (mostly) simultaneous test of the behavioral implications arising from this trust. We explore whether...
Persistent link: https://www.econbiz.de/10012242050
We examine the efficiency gains in health systems generated after the national roll out of basic healthcare in El Salvador between 2010 and 2013. Using data from over 120 million consultations and five million hospitalizations, we demonstrate that the expansion of community health teams,...
Persistent link: https://www.econbiz.de/10014536287
Persistent link: https://www.econbiz.de/10011504610
We examine the challenge entrepreneurial companies face in going beyond the start-up phase and growing into large successful companies. We examine the long-term financing of these so-called scale-up companies, focusing on the United States, Europe and Canada. We first provide a conceptual...
Persistent link: https://www.econbiz.de/10011715715
Start-up growth is often treated as a stylised fact, despite an extensive research body composed of divergent theories and empirical findings. Against this background, this work contributes to the literature by analysing a hand-collected dataset of 2,951 EIF-backed VC start-ups. Section 2...
Persistent link: https://www.econbiz.de/10011863300
Persistent link: https://www.econbiz.de/10012597091
Persistent link: https://www.econbiz.de/10013447945
Innovative startups are frequently acquired by large incumbent firms. On the one hand, these acquisitions provide an incentive for startup creation and may transfer ideas to more efficient users. On the other hand, incumbents might acquire startups just to "kill" their ideas, and acquisitions...
Persistent link: https://www.econbiz.de/10013465631
The paper studies the incentive for providers to invest in new health care technologies under alternative payment systems, when the patients' benefits are uncertain. If the reimbursement by the purchaser includes both a variable (per patient) and a lump-sum component, efficiency can be ensured...
Persistent link: https://www.econbiz.de/10008746927
Persistent link: https://www.econbiz.de/10011302495